BiomX (PHGE) Prepaid Assets (2018 - 2026)
BiomX (PHGE) posted Prepaid Assets of $1.9 million for Q1 2026, up 304.97% sequentially from $463000.0 in Q4 2025, and up 182.38% YoY from $664000.0 in Q1 2025.
BiomX (PHGE) Prepaid Assets (2018 - 2026) Analysis & Trends
BiomX has reported Prepaid Assets for 9 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Prepaid Assets rose 182.38% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 182.38% YoY) and the FY2025 annual result came in at $463000.0, down 51.72% from the prior year.
- Prepaid Assets advanced to $1.9 million in Q1 2026 per PHGE's latest filing, from $463000.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $2.5 million in Q2 2023 and troughed at $84000.0 in Q4 2022.
- A 5-year average of $1.2 million and a median of $1.0 million in 2022 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets sank 97.63% in 2022, then surged 2004.76% in 2023.
- Over 5 years, Prepaid Assets stood at $84000.0 in 2022, then soared by 2004.76% to $1.8 million in 2023, then slumped by 45.76% to $959000.0 in 2024, then plunged by 51.72% to $463000.0 in 2025, then surged by 304.97% to $1.9 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1.9 million, $463000.0, and $88000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | BiomX | 351,774.34 | -816,225.66 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.88 Mn |
| Dec 31, 2025 | 463,000.00 |
| Sep 30, 2025 | 88,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 664,000.00 |
| Dec 31, 2024 | 959,000.00 |
| Sep 30, 2024 | 574,000.00 |
| Jun 30, 2024 | 2.37 Mn |
| Mar 15, 2024 | 1.78 Mn |
| Dec 31, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.91 Mn |
| Jun 30, 2023 | 2.53 Mn |
| Mar 31, 2023 | 129,000.00 |
| Dec 31, 2022 | 84,000.00 |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 2.36 Mn |
| Dec 31, 2021 | 3.54 Mn |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 2.59 Mn |